More on AKBA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.8 Score)
- Holders

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Akebia Therapeutics (NQ:AKBA)
Delayed: 1.07 +0.05 (4.90%)
Prev. Close $1.02  
Open$1.05 
52 Wk High$13.20 
52 Wk Low$7.00 
Day High$1.08 
Day Low$1.00 
P/E N/A  
EPS$0.00 
Volume22,933,787 


Jun 10, 2026 08:02 AM Akebia Therapeutics strengthens Vafseo patent portfolio with new grant
Jun 10, 2026 08:00 AM Akebia Therapeutics Strengthens Vafseo® (vadadustat) Patent Portfolio
Jun 1, 2026 04:05 PM Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 28, 2026 08:00 AM Akebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
May 12, 2026 09:46 AM Form SCHEDULE 13G Akebia Therapeutics, Filed by: STATE STREET CORP
May 7, 2026 07:25 AM Form 10-Q Akebia Therapeutics, For: Mar 31
May 7, 2026 07:08 AM Akebia Therapeutics (AKBA) Misses Q1 EPS by 2c
May 7, 2026 07:06 AM Form 8-K Akebia Therapeutics, For: May 07
May 7, 2026 07:01 AM Akebia Therapeutics Reports First Quarter 2026 Financial Results and Commercial and Pipeline Highlights
May 4, 2026 04:05 PM Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
View All Articles

Entities mentioned with AKBA

View All Entities